๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Issues related to targeted delivery of proteins and peptides

โœ Scribed by Yingjuan Lu; Jun Yang; Emanuela Sega


Book ID
111766845
Publisher
American Association of Pharmaceutical Scientists
Year
2006
Tongue
English
Weight
266 KB
Volume
8
Category
Article
ISSN
1550-7416

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Noninvasive intracellular delivery of fu
โœ Jacek Hawiger ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 160 KB

In order to probe intracellular signaling based on interactions of thousands of proteins expressed in the living cell, new methods of noninvasive delivery of functional peptides and proteins to cells have been developed. These include cellular import of peptides and proteins based on the cell-membra

Proteins and peptides: Strategies for de
โœ Heather A.E. Benson; Sarika Namjoshi ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 460 KB

Despite the increased availability of therapeutic proteins and peptides, delivery remains almost entirely via hypodermic needle. Transdermal delivery offers an attractive noninvasive route of administration but is limited by the skin's barrier to penetration. Extensive research has been directed at

Nonclassical transport proteins and pept
โœ Lisa A. Kueltzo; C. Russell Middaugh ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 250 KB

The number of peptides and proteins known to exhibit nonclassical transport activity has increased significantly in recent years. In most cases, these entities have been studied in relation to their ability to deliver high molecular weight compounds, including proteins and DNA, for the ultimate purp

Construction and evaluation of novel fus
โœ William Lewis; Eli Keshavarz-Moore; John Windust; Donna Bushell; Neil Parry ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 276 KB ๐Ÿ‘ 2 views

## Abstract The use of IgG antibodies and fragments has been limited to specific sectors of the biotechnology industry due to the high cost of producing large batches of product necessary for alternative applications. A novel class of Camelid antibodies, known as V~HH~ offer a more economical oppor